Aseptic craniofacial osteolysis around the implant-bone interface, induced by wear particles, leads to the loosening and failure of dental implants, temporomandibular joint prostheses and internal fixation during maxillofacial reconstruction. Osteoclasts, as terminally differentiated multinucleated giant cells and the exclusive bone resorptive cells, play an important role in this pathological process. The PINK1/Parkin pathway is involved in mitochondrial quality control; however, its effects on osteoclast-mediated physiological bone homeostasis and the therapeutic potential on craniofacial osteolysis remains unexplored. We generated the mutant mice in which Parkin was conditionally deleted in myeloid lineage cells (LysM-Cre/Park2flox/flox; Park2ΔM/ΔM). Unexpectedly, the Park2ΔM/ΔM mice displayed no overall skeletal phenotype. In tandem, upon osteoclastogenic induction, Park2ΔM/ΔM macrophages undergone RANKL-induced osteoclastogenesis normally with compensated increased PINK1 expression. Notably, Mdivi-1 remarkably simultaneously inhibited the PINK1 and Parkin expression, leading to significant attenuated osteoclastogenesis in a concentration-dependent manner. The aseptic titanium particle-induced calvaria erosion model was constructed to simulate craniofacial osteolysis. Importantly, Mdivi-1 effectively alleviated the bone resorption and trabecular structure destruction induced by titanium particles, and blocked the osteoclast accumulation in the lesions. Taken together, Mdivi-1 alleviated titanium particle-induced aseptic craniofacial osteolysis via inhibition of PINK1/Parkin-dependent mitophagy. In summary, while myeloid lineage conditionally deletion of Park2 does not interfere with osteoclast differentiation and physiological bone homeostasis in mice probably due to the compensation by PINK1 expression, Mdivi-1 as the inhibitor of PINK1/Parkin-dependent mitophagy may provide a novel therapeutic strategy towards aseptic craniofacial osteolysis.
扫码关注我们
求助内容:
应助结果提醒方式:
